asa glp-1 agonists Glucagon-Like Peptide-1 Receptor Agonists–Health Professional Version GLP-1 Receptor Agonist Use Is
Description
Table 1: FDA: Food and Drug Administration
Diabetic retinopathy
These results point to heterogeneity between liraglutide and exenatide
In studies, reactions were reported in 1.4% of Wegovy-treated patients and 1.0% of placebo-treated patients
Report any sudden vision change to a doctor right away, and keep the risk in proportion
While the absolute risk remains low, this represents a relative doubling in risk. While our findings should not prompt alarm, they do warrant increased clinical awareness, he continued
